Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/EBIT

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EV/EBIT(x) -0.150.25-0.25-0.170.18

What is the latest EV/EBIT ratio of MANKIND PHARMA ?

The latest EV/EBIT ratio of MANKIND PHARMA is -0.15 based on Mar2023 Consolidated results.
Year EV/EBIT
Mar2023-0.15
Mar20220.25
Mar2021-0.25
Mar2020-0.17
Mar20190.18

How is EV/EBIT of MANKIND PHARMA Trending?

Years EV/EBIT % Change
Mar2023 -0.15
Negative
Mar2022 0.25
Positive
Mar2021 -0.25
Negative
Mar2020 -0.17
Negative
Mar2019 0.18 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/EBIT ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹84,726.9 Cr 1.4% -11.8% 55% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹351,910.0 Cr -4.8% -3.5% 59.7% Stock Analytics
CIPLA ₹119,369.0 Cr 2.4% 5.2% 59.6% Stock Analytics
DIVIS LABORATORIES ₹112,930.0 Cr 5.9% 10.8% 21.8% Stock Analytics
ZYDUS LIFESCIENCES ₹106,515.0 Cr -2.8% 11.3% 112.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,161.7 Cr 1.8% -5.4% 31.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.4%

-11.8%

55%

SENSEX

1.9%

2.1%

21.7%


You may also like the below Video Courses